查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1873575

角膜移植：全球市场份额和排名、总收入和需求预测（2025-2031年）

Corneal Transplant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 98 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球角膜移植市场规模估计为 15.38 亿美元，预计到 2031 年将达到 22.87 亿美元，在预测期（2025-2031 年）内复合年增长率为 6.2%。

角膜移植（角膜成形术）是一种常见的移植手术，成功率非常高，能够用透明、健康的角膜替换有疤痕、疼痛、穿孔、变形或浑浊的角膜（虹膜和瞳孔前的透明层）。

用于移植的角膜取自近期去世的捐赠者。排斥反应相对罕见，且通常可治疗（参见角膜移植併发症）。因此，组织相容性测试并非常规要求。针对水痘角膜病变、圆锥角膜和某些角膜瘢痕等疾病进行的移植手术成功率最高。

广义上讲，角膜移植是指用异体材料取代浑浊或病变的角膜组织，以恢復患者视力、控制角膜疾病或改善外观的手术。因此，它包括同种异体移植、异种移植、自体移植、组织工程角膜移植和人工角膜移植。角膜移植通常指的是同种异体移植，即使用来自其他捐赠者的健康角膜组织来取代浑浊或病变的角膜组织，以恢復视力或控制角膜疾病。它是恢復视力最重要的同种异体移植之一，成功率最高。本研究的范围涵盖在角膜移植过程中产生的各种费用，包括手术费用、耗材费用、角膜费用、麻醉剂以及治疗过程中的废弃物处理费用。

已开发经济体和新兴经济体的人口老化导致角膜变性和疾病的发生率不断上升。

与老龄化相关的角膜内皮功能障碍（Fuchs 内皮营养不良）是内皮移植的常见适应症。

外科技术的进步

与传统 PK 相比，DALK、DSEK 和 DMEK 等微创技术具有恢復更快、视觉效果更好、排斥率更低等优点。

飞秒雷射技术的应用，能够实现精确的切口和移植片的对齐，提高了手术的成功率。

扩大眼库和捐赠者计划

由于公众意识的提高和政府主导的倡议，许多国家的角膜组织捐赠数量正在增加。

角膜保存技术的进步（例如低温保存和器官培养）延长了组织保存期，促进了国际组织交换。

医疗费用支出和扩大保险覆盖范围

开发中国家可支配收入的增加、医疗保健服务的改善以及保险覆盖范围的扩大，都提高了先进眼科手术的可及性。

非营利组织和国际合作在资源匮乏的地区提供外科手术支援。

人工角膜（人工替代物）的创新

对于不适合传统供体移植或反覆移植失败的患者，人工替代物（例如 Boston KPro）带来了希望。

生物相容性材料和设计的进步改善了重症患者的长期治疗效果。

本报告旨在全面概述全球角膜移植市场，重点关注总收入、市场份额和主要企业的排名，并按地区/国家、类型和应用进行分析。

本报告以2024年为基准年，按销售收入提供角膜移植市场规模、估算和预测，并包含2020年至2031年的历史数据和预测数据。透过定量和定性分析，我们帮助读者制定业务/成长策略，评估市场竞争格局，分析公司在当前市场中的地位，并就角膜移植做出明智的商业决策。

市场区隔

公司

  • CryoLife, Inc.
  • Exactech, Inc.
  • Kohler GmbH
  • Lifeline Scientific
  • LIFECELL CORPORATION
  • Medtronic

按类型分類的细分市场

  • 穿孔性角膜移植术
  • 内皮移植
  • Descemet膜剥离自内皮化
  • 角膜缘干细胞移植
  • 其他的

应用领域

  • 医院
  • 眼科诊所
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Corneal Transplant was estimated to be worth US$ 1538 million in 2024 and is forecast to a readjusted size of US$ 2287 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Corneal Transplant (keratoplasty) is a common transplantation procedure with a very high success rate. A scarred, severely painful, perforated, deformed or cloudy cornea (the clear layer in front of the iris and pupil) can be replaced with a clear, healthy cornea.

The donated cornea comes from a recently deceased person. Tissue matching is not routinely required because rejection is relatively rare and can usually be treated (see Complications of corneal transplantation). Transplantation is most likely to be successful when it is performed for diseases such as bullous keratopathy, keratoconus and certain corneal scars.

In a broad sense, corneal transplantation refers to replacing cloudy and diseased corneal tissue with foreign materials to achieve the purpose of restoring the patient's vision or controlling corneal diseases and beauty. Therefore, it includes allogeneic corneal transplantation, xenogeneic corneal transplantation, autologous corneal transplantation, tissue-engineered corneal transplantation and artificial corneal transplantation. Corneal transplantation usually refers to allogeneic corneal transplantation, which is to use normal corneal tissue of a foreign body to replace cloudy or diseased corneal tissue to restore vision or control corneal lesions. It is the one with the highest success rate among allogeneic organ transplants and one of the important eye restoration surgeries. The scope of this report is the various expenses incurred during corneal transplantation, including surgical expenses, consumables, cornea, anesthetic drugs, and various disposal costs during the treatment process.

Aging populations in developed and emerging economies lead to higher rates of corneal degeneration and diseases.

Age-related corneal endothelial failure (Fuchs' dystrophy) is one of the common indications for endothelial keratoplasty.

Advancements in Surgical Techniques

Minimally invasive techniques like DALK, DSEK, and DMEK offer faster recovery, better visual outcomes, and lower rejection rates compared to traditional PK.

The adoption of femtosecond lasers for precise cuts and better graft alignment has improved surgical success rates.

Expansion of Eye Banks and Donor Programs

Improved awareness campaigns and government initiatives have increased corneal tissue donations in many countries.

Technological progress in cornea preservation (e.g., hypothermic storage, organ culture) extends tissue shelf-life and facilitates international tissue exchange.

Increasing Healthcare Expenditure & Insurance Coverage

Rising disposable income, better access to healthcare services, and broader insurance coverage in developing economies boost the affordability of advanced eye surgeries.

Non-profit organizations and international collaborations provide support for surgeries in low-resource settings.

Innovation in Artificial Corneas (Keratoprostheses)

For patients unsuitable for traditional donor grafts or repeat graft failure, keratoprostheses (e.g., Boston KPro) offer hope.

Advances in biocompatible materials and design improve long-term outcomes for severe cases.

This report aims to provide a comprehensive presentation of the global market for Corneal Transplant, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Corneal Transplant by region & country, by Type, and by Application.

The Corneal Transplant market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corneal Transplant.

Market Segmentation

By Company

  • CryoLife, Inc.
  • Exactech, Inc.
  • Kohler GmbH
  • Lifeline Scientific
  • LIFECELL CORPORATION
  • Medtronic

Segment by Type

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Descemet Stripping Automated Endothelial Keratoplasty
  • Corneal Limbal Stem Cell Transplant
  • Others

Segment by Application

  • Hospital
  • Eye Clinics
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Corneal Transplant company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Corneal Transplant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Corneal Transplant in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Corneal Transplant Product Introduction
  • 1.2 Global Corneal Transplant Market Size Forecast (2020-2031)
  • 1.3 Corneal Transplant Market Trends & Drivers
    • 1.3.1 Corneal Transplant Industry Trends
    • 1.3.2 Corneal Transplant Market Drivers & Opportunity
    • 1.3.3 Corneal Transplant Market Challenges
    • 1.3.4 Corneal Transplant Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Corneal Transplant Players Revenue Ranking (2024)
  • 2.2 Global Corneal Transplant Revenue by Company (2020-2025)
  • 2.3 Key Companies Corneal Transplant Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Corneal Transplant Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Corneal Transplant
  • 2.6 Corneal Transplant Market Competitive Analysis
    • 2.6.1 Corneal Transplant Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Corneal Transplant Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corneal Transplant as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Penetrating Keratoplasty
    • 3.1.2 Endothelial Keratoplasty
    • 3.1.3 Descemet Stripping Automated Endothelial Keratoplasty
    • 3.1.4 Corneal Limbal Stem Cell Transplant
    • 3.1.5 Others
  • 3.2 Global Corneal Transplant Sales Value by Type
    • 3.2.1 Global Corneal Transplant Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Corneal Transplant Sales Value, by Type (2020-2031)
    • 3.2.3 Global Corneal Transplant Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Eye Clinics
    • 4.1.3 Others
  • 4.2 Global Corneal Transplant Sales Value by Application
    • 4.2.1 Global Corneal Transplant Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Corneal Transplant Sales Value, by Application (2020-2031)
    • 4.2.3 Global Corneal Transplant Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Corneal Transplant Sales Value by Region
    • 5.1.1 Global Corneal Transplant Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Corneal Transplant Sales Value by Region (2020-2025)
    • 5.1.3 Global Corneal Transplant Sales Value by Region (2026-2031)
    • 5.1.4 Global Corneal Transplant Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Corneal Transplant Sales Value, 2020-2031
    • 5.2.2 North America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Corneal Transplant Sales Value, 2020-2031
    • 5.3.2 Europe Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Corneal Transplant Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Corneal Transplant Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Corneal Transplant Sales Value, 2020-2031
    • 5.5.2 South America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Corneal Transplant Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Corneal Transplant Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Corneal Transplant Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Corneal Transplant Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Corneal Transplant Sales Value, 2020-2031
    • 6.3.2 United States Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Corneal Transplant Sales Value, 2020-2031
    • 6.4.2 Europe Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Corneal Transplant Sales Value, 2020-2031
    • 6.5.2 China Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Corneal Transplant Sales Value, 2020-2031
    • 6.6.2 Japan Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Corneal Transplant Sales Value, 2020-2031
    • 6.7.2 South Korea Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Corneal Transplant Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Corneal Transplant Sales Value, 2020-2031
    • 6.9.2 India Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Corneal Transplant Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CryoLife, Inc.
    • 7.1.1 CryoLife, Inc. Profile
    • 7.1.2 CryoLife, Inc. Main Business
    • 7.1.3 CryoLife, Inc. Corneal Transplant Products, Services and Solutions
    • 7.1.4 CryoLife, Inc. Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.1.5 CryoLife, Inc. Recent Developments
  • 7.2 Exactech, Inc.
    • 7.2.1 Exactech, Inc. Profile
    • 7.2.2 Exactech, Inc. Main Business
    • 7.2.3 Exactech, Inc. Corneal Transplant Products, Services and Solutions
    • 7.2.4 Exactech, Inc. Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Exactech, Inc. Recent Developments
  • 7.3 Kohler GmbH
    • 7.3.1 Kohler GmbH Profile
    • 7.3.2 Kohler GmbH Main Business
    • 7.3.3 Kohler GmbH Corneal Transplant Products, Services and Solutions
    • 7.3.4 Kohler GmbH Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Kohler GmbH Recent Developments
  • 7.4 Lifeline Scientific
    • 7.4.1 Lifeline Scientific Profile
    • 7.4.2 Lifeline Scientific Main Business
    • 7.4.3 Lifeline Scientific Corneal Transplant Products, Services and Solutions
    • 7.4.4 Lifeline Scientific Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Lifeline Scientific Recent Developments
  • 7.5 LIFECELL CORPORATION
    • 7.5.1 LIFECELL CORPORATION Profile
    • 7.5.2 LIFECELL CORPORATION Main Business
    • 7.5.3 LIFECELL CORPORATION Corneal Transplant Products, Services and Solutions
    • 7.5.4 LIFECELL CORPORATION Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.5.5 LIFECELL CORPORATION Recent Developments
  • 7.6 Medtronic
    • 7.6.1 Medtronic Profile
    • 7.6.2 Medtronic Main Business
    • 7.6.3 Medtronic Corneal Transplant Products, Services and Solutions
    • 7.6.4 Medtronic Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Medtronic Recent Developments

8 Industry Chain Analysis

  • 8.1 Corneal Transplant Industrial Chain
  • 8.2 Corneal Transplant Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Corneal Transplant Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Corneal Transplant Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Corneal Transplant Market Trends
  • Table 2. Corneal Transplant Market Drivers & Opportunity
  • Table 3. Corneal Transplant Market Challenges
  • Table 4. Corneal Transplant Market Restraints
  • Table 5. Global Corneal Transplant Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Corneal Transplant Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Corneal Transplant Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Corneal Transplant Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Corneal Transplant
  • Table 10. Global Corneal Transplant Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corneal Transplant as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Corneal Transplant Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Corneal Transplant Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Corneal Transplant Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Corneal Transplant Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Corneal Transplant Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Corneal Transplant Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Corneal Transplant Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Corneal Transplant Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Corneal Transplant Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Corneal Transplant Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Corneal Transplant Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Corneal Transplant Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Corneal Transplant Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Corneal Transplant Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Corneal Transplant Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Corneal Transplant Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Corneal Transplant Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Corneal Transplant Sales Value, (2026-2031) & (US$ Million)
  • Table 31. CryoLife, Inc. Basic Information List
  • Table 32. CryoLife, Inc. Description and Business Overview
  • Table 33. CryoLife, Inc. Corneal Transplant Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Corneal Transplant Business of CryoLife, Inc. (2020-2025)
  • Table 35. CryoLife, Inc. Recent Developments
  • Table 36. Exactech, Inc. Basic Information List
  • Table 37. Exactech, Inc. Description and Business Overview
  • Table 38. Exactech, Inc. Corneal Transplant Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Corneal Transplant Business of Exactech, Inc. (2020-2025)
  • Table 40. Exactech, Inc. Recent Developments
  • Table 41. Kohler GmbH Basic Information List
  • Table 42. Kohler GmbH Description and Business Overview
  • Table 43. Kohler GmbH Corneal Transplant Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Corneal Transplant Business of Kohler GmbH (2020-2025)
  • Table 45. Kohler GmbH Recent Developments
  • Table 46. Lifeline Scientific Basic Information List
  • Table 47. Lifeline Scientific Description and Business Overview
  • Table 48. Lifeline Scientific Corneal Transplant Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Corneal Transplant Business of Lifeline Scientific (2020-2025)
  • Table 50. Lifeline Scientific Recent Developments
  • Table 51. LIFECELL CORPORATION Basic Information List
  • Table 52. LIFECELL CORPORATION Description and Business Overview
  • Table 53. LIFECELL CORPORATION Corneal Transplant Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Corneal Transplant Business of LIFECELL CORPORATION (2020-2025)
  • Table 55. LIFECELL CORPORATION Recent Developments
  • Table 56. Medtronic Basic Information List
  • Table 57. Medtronic Description and Business Overview
  • Table 58. Medtronic Corneal Transplant Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Corneal Transplant Business of Medtronic (2020-2025)
  • Table 60. Medtronic Recent Developments
  • Table 61. Key Raw Materials Lists
  • Table 62. Raw Materials Key Suppliers Lists
  • Table 63. Corneal Transplant Downstream Customers
  • Table 64. Corneal Transplant Distributors List
  • Table 65. Research Programs/Design for This Report
  • Table 66. Key Data Information from Secondary Sources
  • Table 67. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Corneal Transplant Product Picture
  • Figure 2. Global Corneal Transplant Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Corneal Transplant Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Corneal Transplant Report Years Considered
  • Figure 5. Global Corneal Transplant Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Corneal Transplant Revenue in 2024
  • Figure 7. Corneal Transplant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Penetrating Keratoplasty Picture
  • Figure 9. Endothelial Keratoplasty Picture
  • Figure 10. Descemet Stripping Automated Endothelial Keratoplasty Picture
  • Figure 11. Corneal Limbal Stem Cell Transplant Picture
  • Figure 12. Others Picture
  • Figure 13. Global Corneal Transplant Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Corneal Transplant Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Product Picture of Hospital
  • Figure 16. Product Picture of Eye Clinics
  • Figure 17. Product Picture of Others
  • Figure 18. Global Corneal Transplant Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global Corneal Transplant Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America Corneal Transplant Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific Corneal Transplant Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions Corneal Transplant Sales Value (%), (2020-2031)
  • Figure 31. United States Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Corneal Transplant Industrial Chain
  • Figure 53. Corneal Transplant Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed